Q3 2024 |
41 |
$624M |
+$98.5M |
-$115M |
-$16.5M |
APLS, VRNA, GPCR, DNTH, AVBP
|
13F-HR |
11/14/2024, 04:04 PM |
Q2 2024 |
44 |
$606M |
+$90.8M |
-$205M |
-$115M |
APLS, DNTH, GPCR, INSM, DYN
|
13F-HR |
8/14/2024, 04:02 PM |
Q1 2024 |
56 |
$823M |
+$346M |
-$172M |
+$173M |
APLS, ALPN, DNTH, VRNA, DYN
|
13F-HR |
5/15/2024, 04:00 PM |
Q4 2023 |
33 |
$625M |
+$84.4M |
-$175M |
-$91M |
APLS, CBAY, VRNA, INSM, RCUS
|
13F-HR |
2/14/2024, 04:00 PM |
Q3 2023 |
35 |
$568M |
+$100M |
-$99.2M |
+$798K |
APLS, ROIV, CBAY, VRNA, RCUS
|
13F-HR |
11/14/2023, 04:01 PM |
Q2 2023 |
40 |
$717M |
+$90.8M |
-$173M |
-$82.5M |
APLS, VRNA, CBAY, RCUS, ROIV
|
13F-HR |
8/14/2023, 04:00 PM |
Q1 2023 |
35 |
$693M |
+$134M |
-$80.2M |
+$53.8M |
APLS, KDNY, VRNA, CBAY, RCUS
|
13F-HR |
5/15/2023, 04:00 PM |
Q4 2022 |
32 |
$642M |
+$197M |
-$106M |
+$90.5M |
APLS, KDNY, VRNA, RCUS, MRTX
|
13F-HR |
2/14/2023, 04:00 PM |
Q3 2022 |
35 |
$579M |
+$156M |
-$32.9M |
+$123M |
APLS, RCUS, KDNY, HZNP, GOSS
|
13F-HR |
11/14/2022, 04:00 PM |
Q2 2022 |
20 |
$375M |
+$71.5M |
-$69.3M |
+$2.21M |
APLS, RCUS, KDNY, HZNP, GOSS
|
13F-HR |
8/15/2022, 04:00 PM |
Q1 2022 |
24 |
$463M |
+$85M |
-$36.3M |
+$48.7M |
APLS, RCUS, CLDX, FDMT, BBIO
|
13F-HR |
5/16/2022, 04:01 PM |
Q4 2021 |
28 |
$514M |
+$186M |
-$39.1M |
+$147M |
APLS, RCUS, IMAB, FDMT, BBIO
|
13F-HR |
2/14/2022, 04:07 PM |
Q3 2021 |
30 |
$406M |
+$62.2M |
-$110M |
-$48M |
IMAB, APLS, CLDX, RCUS, BBIO
|
13F-HR |
11/15/2021, 04:01 PM |
Q2 2021 |
34 |
$483M |
+$213M |
-$8.6M |
+$204M |
APLS, IMAB, CRIS, BBIO, RCUS
|
13F-HR |
8/16/2021, 04:05 PM |
Q1 2021 |
28 |
$265M |
+$50.6M |
-$52.7M |
-$2.11M |
IMAB, CRIS, APLS, FDMT, XLRN
|
13F-HR |
5/17/2021, 04:01 PM |
Q4 2020 |
31 |
$288M |
$0 |
$0 |
|
APLS, IMAB, CLDX, CRIS, FDMT
|
13F-HR |
2/16/2021, 04:01 PM |